Cormorant Asset Management’s InflaRx IFRX Stock Holding History

Cormorant Asset Management’s Portfolio IFRX Stock Details IFRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-300,000	Closed	-$741K	–	73
2019 Q3	$741K	Sell	300,000 -1,200,000	-80%	-$3.49M	0.05%	71
2019 Q2	$4.74M	Sell	1,500,000 -1,090,000	-42%	-$34.5M	0.27%	60
2019 Q1	$97.9M	Buy	2,590,000 +1,114,860	+76%	+$41.5M	6.62%	1
2018 Q4	$53.7M	Buy	1,475,140 +133,600	+10%	+$4.11M	4.36%	6
2018 Q3	$46M	Sell	1,341,540 -145,725	-10%	-$4.7M	2.99%	10
2018 Q2	$48M	Buy	1,487,265 +88,235	+6%	+$3.05M	3.55%	6
2018 Q1	$40.3M	Sell	1,399,030 -39,177	-3%	-$1.03M	3.01%	6
2017 Q4	$30.1M	Buy	+1,438,207	New	+$26M	3.15%	9

Other funds holding IFRX

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

IBT

International Biotechnology Trust London, United Kingdom $297M AUM 17.25% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Cormorant Asset Management's IFRX Position: Q4 2019 in Review

Cormorant Asset Management sold out of InflaRx (IFRX) in Q4 2019, closing a stake of 300,000 shares — an estimated $741K sold.

Cormorant Asset Management first reported a position in IFRX in Q4 2017 and held it in 8 quarters. The position peaked at $97.9M in Q1 2019. 20 funds tracked by Wall St. Rank hold IFRX as of Q4 2019.

Cormorant Asset Management reported no remaining InflaRx position as of Q4 2019 after selling out during the quarter.
Cormorant Asset Management sold 300,000 InflaRx shares in Q4 2019, an estimated $741K.
Cormorant Asset Management first reported a position in InflaRx in Q4 2017 and held it in 8 quarters.
Cormorant Asset Management's InflaRx position peaked at $97.9M in Q1 2019.
20 funds tracked by Wall St. Rank held InflaRx as of Q4 2019.

Based on Cormorant Asset Management's 13F filing for Q4 2019, filed 14 Feb 2020.